ImmuCell sees growth in livestock health products; India steps up oversight of foot-and-mouth disease;

> ImmuCell ($ICCC), a maker of livestock health products, reported that its product sales in the third quarter grew 43% year over year to $1.77 million and its net operating income was $41,000, versus a loss of $159,000. Release (PDF)

> The government of India has issued quality notices to three manufacturers of vaccines to prevent foot-and-mouth disease (FMD) in livestock, while also setting up a panel to investigate quality issues with FMD vaccines, according to The Economic Times. Article

> Market researcher Global Industry Analysts estimates in a new report that the global market for animal feed additives will grow to $24.7 billion by 2020, driven by growing worldwide demand for safe meat. Release

> China's Skystar Bio-Pharmaceutical ($SKBI), a maker of veterinary medicines and feed additives, announced that its revenues in the third quarter rose 14.8% year over year to $18.4 million and its net income was $4.9 million, up from $3.7 million a year ago. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…